Increase in Hepatocellular carcinoma (HCC) in Hepatitis C (HCV) patients without cirrhosis

被引：0
作者：
Allampati, Sanath K. [1 ]
Krupica, Troy [1 ]
Lopez, Rocio [2 ]
Samaan, Maggie H. [2 ]
Dasarathy, Srinivasan [2 ]
McCullough, Arthur J. [2 ]
机构：
[1] West Virginia Univ, Med, Morgantown, WV USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
997
引用
收藏
页码：534A / 534A
页数：1
相关论文
共 50 条
  • [21] Interferon (IFN) in cirrhosis and chronic hepatitis C for prevention of hepatocellular carcinoma (HCC).
    Simonetti, R
    Pagliaro, L
    HEPATOLOGY, 2001, 34 (04) : 669A - 669A
  • [22] Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosis
    Kutsenko, A.
    Le, A.
    Trinh, S.
    Dang, H.
    Nguyen, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S125 - S126
  • [23] Hepatocellular carcinoma in a patient with chronic hepatitis C without cirrhosis
    Plaza Santos, R.
    Castillo Grau, P.
    Castro Carbajo, P.
    Olveira Martin, A.
    Hidalgo Gutierrez, P.
    Segura Cabral, J. M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (01) : 71 - 72
  • [24] Differential Survival in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma (HBV/HCC) Compared to Hepatitis C Virus-Related Hepatocellular Carcinoma (HCV/HCC)
    Wantuck, James M.
    Wong, Robert J.
    Ha, Nghiem B.
    Yip, Benjamin
    Lin, Hillary
    Lee, Philip
    Ahmed, Aijaz
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2013, 144 (05) : S957 - S957
  • [25] METABOLIC RISK FACTORS INCREASE THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS C CIRRHOSIS
    Kutsenko, Alina
    Le, An K.
    Dang, Hansen
    Trinh, Sam
    Nguyen, Pauline
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1077 - S1077
  • [26] The risk of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis is predicted by a polymorphism of MERTK gene
    Calvaruso, Vincenza
    Grimaudo, Stefania
    Pipitone, Rosaria Maria
    Bavetta, Maria Grazia
    Cabibbo, Giuseppe
    Conte, Elisabetta
    Bronte, Fabrizio
    Craxi, Antonio
    Di Marco, Vito
    HEPATOLOGY, 2014, 60 : 833A - 833A
  • [27] HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH LIVER CIRRHOSIS
    Resuli, B.
    Babameto, A.
    Basho, J.
    Shehu, K.
    Akshia, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 113 - 113
  • [28] Hepatocellular carcinoma (HCC) treated with sorafenib (SFB) and hepatitis C virus (HCV) infection
    Rocha, M.
    Fortuna, A.
    Castro, A.
    Araujo, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [29] IMPACT OF HEPATITIS C VIRUS (HCV) TREATMENT, TYPE OF HEPATOCELLULAR CARCINOMA (HCC) TREATMENT, AND ETHNICITY ON OVERALL SURVIVAL IN PATIENTS WITH HCV-RELATED HCC
    Nguyen, Veronica
    Arteaga, Christopher
    Anderson, Colin
    Cui, Haiyan
    Roe, Denise
    Shroff, Rachna T.
    HEPATOLOGY, 2021, 74 : 647A - 647A
  • [30] HCV-associated hepatocellular carcinoma without cirrhosis
    ElRefaie, A
    Savage, K
    Bhattacharya, S
    Khakoo, S
    Harrison, TJ
    ElBatanony, M
    Soliman, ES
    Nasr, S
    Mokhtar, N
    Amer, K
    Scheuer, PJ
    Dhillon, AP
    JOURNAL OF HEPATOLOGY, 1996, 24 (03) : 277 - 285
12345